InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Myers C. Daniel. Officer active across 2 companies, notably Kala Pharmaceuticals, Inc.. Cumulatively, 3 reports have been published. History available since 22 June 2023. The latest transaction was filed on 11 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations